We have located links that may give you full text access.
Assessment of the Smoke Free Families Tobacco Screening, Counseling, and Referral Program in Pediatric Primary Care Practices.
Academic Pediatrics 2023 May 27
OBJECTIVES: The Smoke Free Families (SFF) program trained pediatric providers to use a SFF tool during well-child visits (WCVs) of infants ≤12 months to "Ask" caregivers about tobacco use, "Advise" smokers to quit, and "Refer" smokers to cessation services (AAR). The primary objectives were to assess the prevalence and changes in caregiver tobacco use after being screened and counseled by providers using the SFF tool. A secondary objective was to examine providers' AAR behavior facilitated by using the SFF tool.
METHODS: Pediatric practices participated in one of three 6-9-month SFF program waves. Over the three waves, all initial SFF tools completed on caregivers during their infant's WCV were evaluated for caregiver and household tobacco use and providers' AAR rates. An infant's first and next WCV were matched to determine changes in caregiver tobacco product use.
RESULTS: In total, the SFF tool was completed at 19,976 WCVs; 2081 (18.8%) infants were exposed to tobacco smoke. A total of 834 (74.1%) caregivers who smoked received counseling: 786 (69.9%) were advised to quit, 700(62.2%) were given cessation resources, and 198 (17.6%) were referred to the Quitline. In total, 230 (27.6%) of caregivers who smoked had a second visit; 58 (25.2%) self-reported that they quit using tobacco. Among cigarette users (n=183), 89 (48.6%) reported that they used fewer cigarettes or quit at their infants' second WCV.
CONCLUSIONS: Systematic use of the SFF AAR tool during infants' WCVs could improve the health of caregivers and children, resulting in decreases in tobacco-related morbidity.
WHAT'S NEW: Pediatric providers incorporated a tool into primary care visits which prompted them to "Ask" about tobacco use, "Advise" caregivers to quit, and "Refer" and provide cessation services/resources (AAR). Routine implementation of AAR could decrease tobacco-related morbidity in caregivers and children.
METHODS: Pediatric practices participated in one of three 6-9-month SFF program waves. Over the three waves, all initial SFF tools completed on caregivers during their infant's WCV were evaluated for caregiver and household tobacco use and providers' AAR rates. An infant's first and next WCV were matched to determine changes in caregiver tobacco product use.
RESULTS: In total, the SFF tool was completed at 19,976 WCVs; 2081 (18.8%) infants were exposed to tobacco smoke. A total of 834 (74.1%) caregivers who smoked received counseling: 786 (69.9%) were advised to quit, 700(62.2%) were given cessation resources, and 198 (17.6%) were referred to the Quitline. In total, 230 (27.6%) of caregivers who smoked had a second visit; 58 (25.2%) self-reported that they quit using tobacco. Among cigarette users (n=183), 89 (48.6%) reported that they used fewer cigarettes or quit at their infants' second WCV.
CONCLUSIONS: Systematic use of the SFF AAR tool during infants' WCVs could improve the health of caregivers and children, resulting in decreases in tobacco-related morbidity.
WHAT'S NEW: Pediatric providers incorporated a tool into primary care visits which prompted them to "Ask" about tobacco use, "Advise" caregivers to quit, and "Refer" and provide cessation services/resources (AAR). Routine implementation of AAR could decrease tobacco-related morbidity in caregivers and children.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app